Sigvaris - Crunchbase Company Profile & Funding

Start Free Trial

Overview

Sigvaris

Heat Score

52

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Sigvaris

CB Rank

712076

Providing eLearning instructional design and development to launch Sigvaris online learning platform.

Founded

obfuscation

Private

Winterthur, Zurich, Switzerland

www.sigvaris.com/en-ch

Details

Also Known As

SIGVARIS GROUP

Operating Status

Active

Company Type

For Profit

Founders

Moritz Ganzoni-Sträuli, Niklaus Barthelts

About the Company

Sigvaris is the global market leader in the manufacture of medical compression garments and celebrated its 150th anniversary in 2014. The company was established in 1864 in Winterthur. For about 100 years, SIGVARIS produced “rubber-elastic textiles”, which it sold both in Switzerland and abroad.

Phone Number

41 52 265 00 00

Contact Email

services.consommateurs@sigvaris.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Medical Compression Stockings

Elastic hosiery designed to apply controlled pressure to the legs to improve venous circulation and reduce symptoms like swelling and heaviness.

Support Stockings by SIGVARIS

Medical support stockings designed to alleviate venous symptoms like tired or swollen legs by providing mild compression.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Market Intelligence

People

View Profiles & Contacts

Headcount

Contacts

News

News and Press

News•

Apr 9, 2025

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

Access a complete feed of recent news and press, from product launches to leadership changes.

Technology

View Tech Report

Monthly Web Visits

110,552

12.9%

in past month

IT Spend

$3.7M

This year,

is projected to spend

on IT, according to Aberdeen.

Interest Signals

Topic	Surge Score
Apple ARKit	100
Loan payments	98
Prebankruptcy Planning	97

Actively Used Products

29

uses

29

technology products and services including

,

, and

, according to G2 Stack.

Active Website Tech Count

71

is actively using

71

technologies for its website, according to BuiltWith. These include

,

, and

Mobile Non Scaleable Content

.

Total IP

210

The intellectual property of

includes

registered patents primarily in the '

Medical Or Veterinary Science; Hygiene

' category, according to IPqwery. Additionally,

has registered

trademarks with the most popular class being '

Medical apparatus and instruments

', according to IPqwery.

Lists Featuring This Company

Lists Featuring This Company

Medical Device Companies With More Than $10M in Revenue

4,913 Number of Organizations • $196.3B Total Funding Amount • 4,757 Number of Investors

Switzerland Companies With More Than 10 Employees (Top 10K)

9,731 Number of Organizations • $238B Total Funding Amount • 7,234 Number of Investors

News Companies With More Than 100 Employees

4,021 Number of Organizations • $101.7B Total Funding Amount • 1,197 Number of Investors

Social News Companies

4,079 Number of Organizations • $4.4B Total Funding Amount • 350 Number of Investors

Sub-Organizations

Frequently Asked Questions

Where is

's headquarters?

is located in

Winterthur, Zurich, Switzerland

.

Who are

's competitors? Alternatives and possible competitors to

may include

,

, and

.